$28.91
0.130.45%
At Close: -
$28.91
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Arrowhead Pharma
ARWRNASDAQ
Arrowhead Pharma (NASDAQ:ARWR) Stock, Earnings Estimates, EPS, And Revenue
Arrowhead Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 8
EPS Estimate
$-0.550
Quarterly Revenue Estimate
$52.6M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$35.5M
Analyze the earnings history of Arrowhead Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARWR | Arrowhead Pharma | -$0.96 | -$0.55 | — | — | $15.82M | $52.63M | — | — | 08/08/2024 | Get Alert |
| ARWR | Arrowhead Pharma | $0.45 | -$0.16 | -$1.02 | -537.50% | $146.27M | — | $0.00 | — | 05/09/2024 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.39 | -$0.82 | -$1.24 | -51.22% | $62.55M | $29.51M | $3.55M | -87.97% | 02/06/2024 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.81 | -$0.60 | -$1.02 | -70.00% | $31.57M | $50.73M | $16.10M | -68.27% | 11/29/2023 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.68 | -$0.58 | -$0.96 | -65.52% | $32.41M | $48.19M | $15.82M | -67.16% | 08/07/2023 | Get Alert |
| ARWR | Arrowhead Pharma | $0.41 | -$0.64 | $0.45 | 170.31% | $151.81M | $45.48M | $146.27M | 221.61% | 05/02/2023 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.60 | $0.44 | -$0.39 | -188.64% | $27.44M | $162.52M | $62.55M | -61.51% | 02/06/2023 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.61 | -$0.16 | -$0.81 | -406.25% | $38.28M | $50.44M | $31.57M | -37.40% | 11/28/2022 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.29 | -$0.51 | -$0.68 | -33.33% | $45.89M | $55.23M | $32.41M | -41.31% | 08/04/2022 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.26 | -$0.08 | $0.41 | 612.50% | $32.81M | $108.91M | $151.81M | 39.39% | 05/10/2022 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.20 | -$0.45 | -$0.60 | -33.33% | $21.30M | $51.04M | $27.44M | -46.24% | 02/02/2022 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.48 | -$0.10 | -$0.61 | -510.00% | $7.63M | $56.77M | $38.28M | -32.56% | 11/22/2021 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.13 | -$0.20 | -$0.29 | -45.00% | $27.38M | $37.52M | $45.89M | 22.31% | 08/05/2021 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.20 | -$0.13 | -$0.26 | -100.00% | $23.53M | $37.70M | $32.81M | -12.97% | 05/04/2021 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.03 | $0.17 | -$0.20 | -217.65% | $29.45M | $86.69M | $21.30M | -75.43% | 02/04/2021 | Get Alert |
| ARWR | Arrowhead Pharma | $0.11 | $0.12 | -$0.48 | -500.00% | $43.29M | $49.24M | $7.63M | -84.50% | 11/23/2020 | Get Alert |
| ARWR | Arrowhead Pharma | $0.21 | -$0.12 | -$0.13 | -8.33% | $42.70M | $28.91M | $27.38M | -5.31% | 08/05/2020 | Get Alert |
| ARWR | Arrowhead Pharma | $0.24 | -$0.11 | -$0.20 | -81.82% | $48.15M | $21.74M | $23.53M | 8.23% | 05/07/2020 | Get Alert |
| ARWR | Arrowhead Pharma | $0.13 | -$0.01 | -$0.03 | -200.00% | $34.66M | $29.50M | $29.45M | -0.15% | 02/05/2020 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.12 | — | $0.11 | — | $11.26M | — | $43.29M | — | 11/25/2019 | Get Alert |
| ARWR | Arrowhead Pharma | -$0.18 | $0.29 | $0.21 | -27.59% | $727.38K | $54.37M | $42.70M | -21.47% | 08/05/2019 | Get Alert |
Arrowhead Pharma (ARWR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-1.02 | $-0.16 | -537.5 % |
| Dec 2023 | 2024-02-06 | $-1.24 | $-0.82 | -51.2 % |
| Sep 2023 | 2023-11-29 | $-1.02 | $-0.60 | -70.0 % |
| Jun 2023 | 2023-08-07 | $-0.96 | $-0.58 | -65.5 % |
Arrowhead Pharma (ARWR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-02-06 | $3.55M | $29.51M | -88.0 % |
| Sep 2023 | 2023-11-29 | $16.10M | $50.73M | -68.3 % |
| Jun 2023 | 2023-08-07 | $15.83M | $48.19M | -67.2 % |
| Mar 2023 | 2023-05-02 | $146.27M | $45.48M | 221.6 % |
FAQ
When is Arrowhead Pharma (NASDAQ:ARWR) reporting earnings?
Arrowhead Pharma (ARWR) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 9, 2024 for Q2.
What were the latest earnings per share (EPS) for Arrowhead Pharma (NASDAQ:ARWR)?
The Actual EPS was $-1.02, which missed the estimate of $-0.16.
What were Arrowhead Pharma’s (NASDAQ:ARWR) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.